type here...

CATEGORIES

Medication

LATEST

1234Page 4 of 4

TRENDING

EDITORS CHOICE

Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction

Medika Life -
DANDRIDGE, Tenn. — Rachel Solomon and judges hadn’t been on the best of terms. Then Judge O. Duane Slone “dumbfounded” her. Solomon was given...

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Beyond Stereotypes: The Exceptional Abilities That Make Autistic Minds Invaluable

Pat Farrell PhD -
According to The Lancet (in 2021), there were 61.8 million people on the autism spectrum in the world, which is equivalent to 1 out...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories